Solution-oriented professional with 20+ years of experience in clinical development and market access for health technologies. Expertise in health technology assessment (HTA) and health policies, managing diverse market access projects across various therapeutic areas. Recognized for strong organizational skills and ability to excel in collaborative, cross-functional teams.
Product areas: orphan drugs, ATMPs/regenerative medicines, immuno-oncology products, biosimilars, generics, value added medicines, vaccines, medical devices/diagnostics and medical procedures
Therapeutic areas: rare diseases, oncology, dermatology, ophtalmology, hematology, neurology/psychiatry, cardio-metabolic disorders, gastroenterology, immunology, infectious diseases, nephrology, respiratory diseases